Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is Holding a Web-Meeting
Marijuana Investing
EVIO, Inc. (EVIO) Announces Strong Start to Fiscal 2018
EVIO, Inc. (OTCQB: EVIO) this morning announced that its EVIO Labs division has already exceeded last October’s testing revenues through the first half of October 2017.
ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF) Announces Close of $15 Million Investment from Cannabis Wheaton
ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced the completion of Cannabis Wheaton Income Corp.’s (TSX.V: CBW) previously detailed purchase of $15 million of ABcann common shares at an agreed upon valuation of $2.25 per share.
India Globalization Capital (NYSE: IGC) Achieves Breakthrough with Potential to Prevent, Combat Alzheimer’s
India Globalization Capital (NYSE MKT: IGC), a first mover in the cannabis-based combination therapy space, recently announced that it is readying a line of cannabis-based medical dispensary products that target Alzheimer’s disease.
ABcann Medicinals (TSXV: ABCN) Has Strong Start with Canadian TSX Venture Exchange Listing
Going public appears to be paying off for ABcann Medicals (TSXV: ABCN), since the medical cannabis grower launched its initial public offering (IPO) on the TSX Venture Exchange.
ABcann Global Corporation (TSXV: ABCN) Enters Definitive Agreement for $15 Million Investment
ABcann Global Corporation (TSXV: ABCN) this morning announced the signing of a definitive subscription agreement with Cannabis Wheaton Income Corp. (TSXV: CBW).
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Highlights Positive Pre-Clinical Data Related to Biosynthesis Platform
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced results from a study co-sponsored by InMed and the University of British Columbia.
ABcann Global Corporation (ABCN:CA) Appoints W. Brett Wilson to Advisory Board
In a news release issued earlier this week, ABcann Global Corporation (ABCN:CA) announced the appointment of W. Brett Wilson to its advisory board in connection with the company’s acquisition of ABcann Medicinals Inc.
PotNetwork Holding, Inc. (POTN) Subsidiary on Pace for Record-Breaking Quarter
PotNetwork Holding, Inc. (OTC: POTN) today announced that its wholly owned subsidiary, Diamond CBD, Inc., achieved combined sales of more than $3.2 million for July and August.
Marijuana Company of America (MCOA) Stands Out among Cannabis and Hemp Industry Innovators
Marijuana Company of America, Inc. (OTC: MCOA) is among those managing to shine in spite of the growing competition, successfully carving out a niche with its unique, strategic approach and distinctive business model.
India Globalization Capital, Inc. (NYSE: IGC) Management Quoted in “HIGH TIMES” Article
India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced the publication of “Marijuana Could Help Treat Alzheimer’s: Here’s How It Would Work” on August 1, 2017, by Javier Hasse on the website of “HIGH TIMES,” a publication that’s served as the preeminent source for cannabis information since 1974.
ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF) Announces Close of $15 Million Investment from Cannabis Wheaton
ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced the completion of Cannabis Wheaton Income Corp.’s (TSX.V: CBW) previously detailed purchase of $15 million of ABcann common shares at an agreed upon valuation of $2.25 per share.
Marijuana Company of America Announces a $5 Million Fixed Funding Commitment
MARIJUANA COMPANY OF AMERICA, INC; (OTC PINK: MCOA), an innovative cannabis and hemp marketing and distribution company, announced today that it has signed an investment agreement with Tangiers Global, LLC ('Tangiers') for a Fixed Funding Commitment which will provide the Company with an equity investment of up to $5 million.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Technology Set to Benefit as Study Shows More Benefits of Cannabidiol
A new scientific review of the safety and side effects of cannabidiol confirms and expands on the myriad known health benefits of cannabidiol and the compound’s lack of side effects.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Research Published in the European Journal of Pain
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced the publication of company-sponsored research in the European Journal of Pain.